Literature DB >> 14587298

Membrane-type 1 matrix metalloproteinase and cell migration.

Motoharu Seiki1, Hidetoshi Mori, Masahiro Kajita, Takamasa Uekita, Yoshifumi Itoh.   

Abstract

Membrane-type 1 matrix metalloproteinase (MT1-MMP) is an integral membrane proteinase that performs processing of cell surface proteins and degradation of extracellular matrix (ECM) components. Through these proteolytic events, MT1-MMP regulates various cellular functions, including ECM turnover, promotion of cell migration and invasion, and morphogenic responses to extracellular stimuli. MT1-MMP has to be regulated strictly to accomplish its function appropriately at various steps, including at the transcriptional and post-translational levels. MT1-MMP was originally identified as an invasion-promoting enzyme expressed in malignant tumour cells, and also as a specific activator of proMMP-2, which is believed to play a role in invasion of the basement membrane. Since then, it has attracted attention as a membrane-associated MMP that promotes cancer cell invasion and angiogenesis by endothelial cells. Although MT1-MMP has now become one of the best characterized enzymes in the MMP family, there remain numerous unanswered questions. In this chapter, we summarize our recent findings on how MT1-MMP is regulated during cell migration, and how cell migration is regulated by MT1-MMP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14587298     DOI: 10.1042/bss0700253

Source DB:  PubMed          Journal:  Biochem Soc Symp        ISSN: 0067-8694


  13 in total

1.  MT1-MMP: A novel component of the macrophage cell fusion machinery.

Authors:  Pilar Gonzalo; Alicia G Arroyo
Journal:  Commun Integr Biol       Date:  2010-05

2.  Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion.

Authors:  Rubén A Bartolomé; Isabel Molina-Ortiz; Rafael Samaniego; Paloma Sánchez-Mateos; Xosé R Bustelo; Joaquin Teixidó
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

3.  Function of EWS-POU5F1 in sarcomagenesis and tumor cell maintenance.

Authors:  Takashi Fujino; Kimie Nomura; Yuichi Ishikawa; Hatsune Makino; Akihiro Umezawa; Hiroyuki Aburatani; Koichi Nagasaki; Takuro Nakamura
Journal:  Am J Pathol       Date:  2010-03-04       Impact factor: 4.307

4.  MT1-MMP-mediated cleavage of decorin in corneal angiogenesis.

Authors:  Tatsuya Mimura; Kyu Yeon Han; Tatsuya Onguchi; Jin-Hong Chang; Tae-im Kim; Takashi Kojima; Zhongjun Zhou; Dimitri T Azar
Journal:  J Vasc Res       Date:  2009-06-30       Impact factor: 1.934

5.  Activation of caspases-8 and -10 by FLIP(L).

Authors:  Kelly M Boatright; Cristina Deis; Jean-Bernard Denault; Daniel P Sutherlin; Guy S Salvesen
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

6.  Regulation of membrane-type 1 matrix metalloproteinase expression by zonula occludens-2 in human lung cancer cells.

Authors:  E Luczka; L Syne; B Nawrocki-Raby; C Kileztky; W Hunziker; P Birembaut; C Gilles; Myriam Polette
Journal:  Clin Exp Metastasis       Date:  2013-04-21       Impact factor: 5.150

7.  Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity.

Authors:  Yasuhiro Funahashi; Carrie J Shawber; Anshula Sharma; Emi Kanamaru; Yun K Choi; Jan Kitajewski
Journal:  Vasc Cell       Date:  2011-01-18

8.  Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase.

Authors:  Brenda L Petrella; Constance E Brinckerhoff
Journal:  Mol Cancer       Date:  2006-12-01       Impact factor: 27.401

9.  Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.

Authors:  Kevin E Fisher; Andreia Pop; Wonshill Koh; Nicholas J Anthis; W Brian Saunders; George E Davis
Journal:  Mol Cancer       Date:  2006-12-08       Impact factor: 27.401

10.  Membrane localization of membrane type 1 matrix metalloproteinase by CD44 regulates the activation of pro-matrix metalloproteinase 9 in osteoclasts.

Authors:  Meenakshi A Chellaiah; Tao Ma
Journal:  Biomed Res Int       Date:  2013-07-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.